Organization and functions of mGlu and GABA B receptor complexes

Nature

Volumn 540, Issue 7631, 2016, Pages 60-68

  Pin, Jean Philippe ^a,b   Bettler, Bernhard ^c  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; HYDROXYBUTYRIC ACID; METABOTROPIC RECEPTOR; MULTIPROTEIN COMPLEX; OLIGOMER; PROTEIN HOMER; REGULATOR PROTEIN; RETINA S ANTIGEN; BETA 2 ADRENERGIC RECEPTOR;

ENZYME ACTIVITY; GENE EXPRESSION; LIGAND; MENTAL HEALTH; METABOLISM; PROTEIN;

ALLOSTERISM; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG TARGETING; HUMAN; INTERNALIZATION; INTRACELLULAR SIGNALING; MENTAL DISEASE; MENTAL HEALTH; MOLECULAR DYNAMICS; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; PROTEOMICS; RECEPTOR DENSITY; REVIEW; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY; ANIMAL; ANTAGONISTS AND INHIBITORS; BINDING SITE; CHEMISTRY; DRUG DEVELOPMENT; METABOLISM;

ALLOSTERIC SITE; ANIMALS; DRUG DISCOVERY; HUMANS; MULTIPROTEIN COMPLEXES; PROTEIN INTERACTION MAPS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, GABA-B; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 85000366245     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature20566     Document Type: Review

References (99)

1. Gassmann, M., Bettler, B. Regulation of neuronal GABAB receptor functionsby subunit composition. Nat. Rev. Neurosci. 13, 380-394 (2012).
2. Niswender, C. M., Conn, P. J. Metabotropic glutamate receptors: physiology,pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295-322 (2010).
3. Froestl, W. Chemistry and pharmacology of GABAB receptor ligands. Adv.Pharmacol. 58, 19-62 (2010).
4. Nickols, H. H., Conn, P. J. Development of allosteric modulators of GPCRs fortreatment of CNS disorders. Neurobiol. Dis. 61, 55-71 (2014).
5. Bennett, K. A., Doré, A. S., Christopher, J. A., Weiss, D. R., Marshall, F. H.Structures of mGluRs shed light on the challenges of drug development ofallosteric modulators. Curr. Opin. Pharmacol. 20, 1-7 (2015).
6. Kniazeff, J., Prézeau, L., Rondard, P., Pin, J. P., Goudet, C. Dimers and beyond:the functional puzzles of class C GPCRs. Pharmacol. Ther. 130, 9-25 (2011).
7. Marshall, F. H., Jones, K. A., Kaupmann, K., Bettler, B. GABAB receptors-thefirst 7TM heterodimers. Trends Pharmacol. Sci. 20, 396-399 (1999).
8. Hannan, S., Gerrow, K., Triller, A., Smart, T. G. Phospho-dependentaccumulation of GABABRs at presynaptic terminals after NMDAR activation.Cell Reports 16, 1962-1973 (2016).
9. Doumazane, E., et al. A new approach to analyze cell surface proteincomplexes reveals specific heterodimeric metabotropic glutamate receptors.FASEB J. 25, 66-77 (2011).
10. Comps-Agrar, L., et al. The oligomeric state sets GABAB receptor signallingefficacy. EMBO J. 30, 2336-2349 (2011).
11. Schwenk, J., et al. Native GABAB receptors are heteromultimers with a family ofauxiliary subunits. Nature 465, 231-235 (2010).Proteomic identification of the KCTD proteins that constitutively associatewith the GABAB2 subunit of GABABRs and regulate the kinetics ofG signalling to K+ and Ca2+ effector channels
12. Schwenk, J., et al. Modular composition and dynamics of native GABABreceptors identified by high-resolution proteomics. Nat. Neurosci. 19,233-242 (2016).Comprehensive proteomic study reporting the GABABR interactome in therodent brain, including a functional characterization of the interaction ofGABABRs with hyperpolarization-activated cyclic-nucleotide-gated HCNchannels.
13. Galvez, T., et al. Allosteric interactions between GB1 and GB2 subunits arerequired for optimal GABAB receptor function. EMBO J. 20, 2152-2159(2001).
14. Marsh, J. A., et al. Protein complexes are under evolutionary selection toassemble via ordered pathways. Cell 153, 461-470 (2013).
15. Doly, S., et al. GABA receptor cell-surface export is controlled by anendoplasmic reticulum gatekeeper. Mol. Psychiatry 21, 480-490 (2016).
16. Burmakina, S., Geng, Y., Chen, Y., Fan, Q. R. Heterodimeric coiled-coilinteractions of human GABAB receptor. Proc. Natl Acad. Sci. USA 111,6958-6963 (2014).
17. Maurel, D., et al. Cell-surface protein-protein interaction analysis withtime-resolved FRET and snap-tag technologies: application to GPCRoligomerization. Nat. Methods 5, 561-567 (2008).
18. Kniazeff, J., et al. Closed state of both binding domains of homodimeric mGlureceptors is required for full activity. Nat. Struct. Mol. Biol. 11, 706-713(2004).
19. Gavalas, A., et al. Segregation of family A G protein-coupled receptor protomersin the plasma membrane. Mol. Pharmacol. 84, 346-352 (2013).
20. El Moustaine, D., et al. Distinct roles of metabotropic glutamate receptordimerization in agonist activation and G-protein coupling. Proc. Natl Acad. Sci.USA 109, 16342-16347 (2012).
21. Yin, S., et al. Selective actions of novel allosteric modulators reveal functionalheteromers of metabotropic glutamate receptors in the CNS. J. Neurosci. 34,79-94 (2014).
22. Pandya, N. J., et al. Group 1 metabotropic glutamate receptors 1 and 5 form aprotein complex in mouse hippocampus and cortex. Proteomics 16,2698-2705 (2016).
23. Comps-Agrar, L., Kniazeff, J., Brock, C., Trinquet, E., Pin, J. P. Stability ofGABAB receptor oligomers revealed by dual TR-FRET and drug-induced cellsurface targeting. FASEB J. 26, 3430-3439 (2012).
24. Calebiro, D., et al. Single-molecule analysis of fluorescently labeled G-proteincoupledreceptors reveals complexes with distinct dynamics and organization.Proc. Natl Acad. Sci. USA 110, 743-748 (2013).
25. Sobolevsky, A. I., Rosconi, M. P., Gouaux, E. X-ray structure, symmetry andmechanism of an AMPA-subtype glutamate receptor. Nature 462, 745-756(2009).
26. Kunishima, N., et al. Structural basis of glutamate recognition by a dimericmetabotropic glutamate receptor. Nature 407, 971-977 (2000).
27. Tsuchiya, D., Kunishima, N., Kamiya, N., Jingami, H., Morikawa, K. Structuralviews of the ligand-binding cores of a metabotropic glutamate receptorcomplexed with an antagonist and both glutamate and Gd3+. Proc. Natl Acad.Sci. USA 99, 2660-2665 (2002).
28. Muto, T., Tsuchiya, D., Morikawa, K., Jingami, H. Structures of the extracellularregions of the group II/III metabotropic glutamate receptors. Proc. Natl Acad.Sci. USA 104, 3759-3764 (2007).
29. Geng, Y., Bush, M., Mosyak, L., Wang, F., Fan, Q. R. Structural mechanism ofligand activation in human GABAB receptor. Nature 504, 254-259 (2013).Crystal structures of the heterodimeric extracellular domains of GABAB1 andGABAB2 in the empty, agonist-bound and antagonist-bound forms, revealthat receptor activation involves the formation of a novel interface betweensubunits.
30. Kniazeff, J., et al. Locking the dimeric GABAB G-protein-coupled receptor in itsactive state. J. Neurosci. 24, 370-377 (2004).
31. Bessis, A.-S., et al. Closure of the Venus flytrap module of mGlu8 receptor andthe activation process: insights from mutations converting antagonists intoagonists. Proc. Natl Acad. Sci. USA 99, 11097-11102 (2002).
32. Geng, Y., et al. Structure and functional interaction of the extracellular domainof human GABAB receptor GBR2. Nat. Neurosci. 15, 970-978 (2012).
33. Doré, A. S., et al. Structure of class C GPCR metabotropic glutamate receptor 5transmembrane domain. Nature 511, 557-562 (2014).
34. Wu, H., et al. Structure of a class C GPCR metabotropic glutamate receptor 1bound to an allosteric modulator. Science 344, 58-64 (2014).
35. Christopher, J. A., et al. Fragment and structure-based drug discovery for aclass C GPCR: discovery of the mGlu5 negative allosteric modulatorHTL14242 (3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).J. Med. Chem. 58, 6653-6664 (2015).
36. Chen, Y., Goudet, C., Pin, J.-P., Conn, P. J. N. N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) actsthrough a novel site as a positive allosteric modulator of group 1 metabotropicglutamate receptors. Mol. Pharmacol. 73, 909-918 (2008).
37. Rovira, X., et al. Overlapping binding sites drive allosteric agonism and positivecooperativity in type 4 metabotropic glutamate receptors. FASEB J. 29,116-130 (2015).
38. Ango, F., et al. Agonist-independent activation of metabotropic glutamatereceptors by the intracellular protein Homer. Nature 411, 962-965(2001).
39. Rodriguez, A. L., et al. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamatereceptor subtype 5 and blocks the effects of multiple allosteric modulators.Mol. Pharmacol. 68, 1793-1802 (2005).
40. Rook, J. M., et al. Biased mGlu5-positive allosteric modulators provide in vivoefficacy without potentiating mGlu5 modulation of NMDAR currents. Neuron86, 1029-1040 (2015).Development of a biased mGlu5 PAM with therapeutic efficacy and animproved side-effect profile.
41. Binet, V., et al. Common structural requirements for heptahelical domainfunction in class A and class C G protein-coupled receptors. J. Biol. Chem. 282,12154-12163 (2007).
42. Doumazane, E., et al. Illuminating the activation mechanisms and allostericproperties of metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA 110,E1416-E1425 (2013).
43. Olofsson, L., et al. Fine tuning of sub-millisecond conformational dynamicscontrols metabotropic glutamate receptors agonist efficacy. Nat. Commun. 5,5206 (2014).
44. Vafabakhsh, R., Levitz, J., Isacoff, E. Y. Conformational dynamics of a class CG-protein-coupled receptor. Nature 524, 497-501 (2015).
45. Huang, S., et al. Interdomain movements in metabotropic glutamate receptoractivation. Proc. Natl Acad. Sci. USA 108, 15480-15485,2011
46. Tateyama, M., Abe, H., Nakata, H., Saito, O., Kubo, Y. Ligand-inducedrearrangement of the dimeric metabotropic glutamate receptor 1 .Nat. Struct. Mol. Biol. 11, 637-642 (2004).
47. Hlavackova, V., et al. Sequential inter-and intrasubunit rearrangements duringactivation of dimeric metabotropic glutamate receptor 1. Sci. Signal. 5, 59(2012).
48. Hlavackova, V., et al. Evidence for a single heptahelical domain being turned onupon activation of a dimeric GPCR. EMBO J. 24, 499-509 (2005).
49. Xue, L., et al. Major ligand-induced rearrangement of the heptahelical domaininterface in a GPCR dimer. Nat. Chem. Biol. 11, 134-140 (2015).
50. Maurice, P., Kamal, M. & Jockers, R. Asymmetry of GPCR oligomers supports their functional relevance. Trends Pharmacol. Sci. 32, 514-520 (2011).
51. Monnier, C., et al. Trans-activation between 7TM domains: implication inheterodimeric GABAB receptor activation. EMBO J. 30, 32-42 (2011).
52. Goudet, C., et al. Asymmetric functioning of dimeric metabotropic glutamatereceptors disclosed by positive allosteric modulators. J. Biol. Chem. 280,24380-24385 (2005).
53. Sun, B., et al. A negative allosteric modulator modulates GABAB-receptorsignalling through GB2 subunits. Biochem. J. 473, 779-787 (2016).
54. Goudet, C., et al. Heptahelical domain of metabotropic glutamate receptor 5behaves like rhodopsin-like receptors. Proc. Natl Acad. Sci. USA 101, 378-383(2004).
55. Lefkowitz, R. J. Arrestins come of age: a personal historical perspective. Prog.Mol. Biol. Transl. Sci. 118, 3-18 (2013).
56. Iacovelli, L., Nicoletti, F., De Blasi, A. Molecular mechanisms that desensitizemetabotropic glutamate receptor signaling: an overview. Neuropharmacology66, 24-30 (2013).
57. Perroy, J., Adam, L., Qanbar, R., Chénier, S., Bouvier, M. Phosphorylationindependentdesensitization of GABAB receptor by GRK4. EMBO J. 22,3816-3824 (2003).
58. Fourgeaud, L., et al. The metabotropic glutamate receptor mGluR5 isendocytosed by a clathrin-independent pathway. J. Biol. Chem. 278,12222-12230 (2003).
59. Fairfax, B. P., et al. Phosphorylation and chronic agonist treatment atypicallymodulate GABAB receptor cell surface stability. J. Biol. Chem. 279,12565-12573 (2004).
60. Lujan, R., Ciruela, F. GABAB receptors-associated proteins: potential drugtargets in neurological disorders Curr. Drug Targets 13, 129-144(2012).
61. Bettler, B., Tiao, J. Y. Molecular diversity, trafficking and subcellularlocalization of GABAB receptors. Pharmacol. Ther. 110, 533-543 (2006).
62. Benke, D. GABAB receptor trafficking and interacting proteins: targets for thedevelopment of highly specific therapeutic strategies to treat neurologicaldisorders Biochem. Pharmacol. 86, 1525-1530 (2013).
63. Bockaert, J., Perroy, J., Bécamel, C., Marin, P., Fagni, L. GPCR interactingproteins (GIPs) in the nervous system: roles in physiology and pathologies.Annu. Rev. Pharmacol. Toxicol. 50, 89-109 (2010).
64. Enz, R. Metabotropic glutamate receptors and interacting proteins: evolvingdrug targets. Curr. Drug Targets 13, 145-156 (2012).
65. Turecek, R., et al. Auxiliary GABAB receptor subunits uncouple G protein subunits from effector channels to induce desensitization. Neuron 82,1032-1044 (2014).
66. Tolkovsky, A. M., Levitzki, A. Mode of coupling between the-adrenergicreceptor and adenylate cyclase in turkey erythrocytes. Biochemistry 17,3795 (1978).
67. Rajalu, M., et al. Pharmacological characterization of GABAB receptor subtypesassembled with auxiliary KCTD subunits. Neuropharmacology 88, 145-154(2015).
68. Hanack, C., et al. GABA blocks pathological but not acute TRPV1 pain signals. Cell160, 759-770 (2015).
69. Valdés, V., et al. Endoplasmic reticulum sorting and kinesin-1 command thetargeting of axonal GABAB receptors. PLoS One 7, e44168 (2012).
70. Verhey, K. J., et al. Cargo of kinesin identified as JIP scaffolding proteins andassociated signaling molecules. J. Cell Biol. 152, 959-970 (2001).
71. Ludwig, A., et al. Calsyntenins mediate TGN exit of APP in a kinesin-1-dependent manner. Traffic 10, 572-589 (2009).
72. Laffray, S., et al. Impairment of GABAB receptor dimer by endogenous 14-3-3in chronic pain conditions. EMBO J. 31, 3239-3251 (2012).
73. Workman, E. R., et al. Rapid antidepressants stimulate the decoupling ofGABAB receptors from GIRK/Kir3 channels through increased protein stabilityof 14-3-3 . Mol. Psychiatry 20, 298-310 (2015).
74. Cabello, N., et al. Metabotropic glutamate type 5, dopamine D2 and adenosineA2a receptors form higher-order oligomers in living cells. J. Neurochem. 109,1497-1507 (2009).
75. Fribourg, M., et al. Decoding the signaling of a GPCR heteromeric complexreveals a unifying mechanism of action of antipsychotic drugs. Cell 147,1011-1023 (2011).
76. Akgün, E., et al. Ligands that interact with putative MOR-mGluR5 heteromer inmice with inflammatory pain produce potent antinociception. Proc. Natl Acad.Sci. USA 110, 11595-11599 (2013).
77. Wright, S. R., et al. A critical role of striatal A2A R-mGlu5 R interactions inmodulating the psychomotor and drug-seeking effects of methamphetamine.Addict. Biol. 21, 811-825 (2016).
78. Beggiato, S., et al. Functional role of striatal A2A, D2, and mGlu5 receptorinteractions in regulating striatopallidal GABA neuronal transmission.J. Neurochem. 138, 254-264 (2016).
79. Kenakin, T. The effective application of biased signaling to new drug discovery.Mol. Pharmacol. 88, 1055-1061 (2015).
80. Hu, J. H., et al. Homeostatic scaling requires group I mGluR activationmediated by Homer1a. Neuron 68, 1128-1142 (2010).
81. Ronesi, J.A., et al. Disrupted Homer scaffolds mediate abnormal mGluR5function in a mouse model of fragile X syndrome. Nat. Neurosci. 15,431-440 (2012).
82. Gentry, P. R., Sexton, P. M., Christopoulos, A. Novel allosteric modulators of Gprotein-coupled receptors. J. Biol. Chem. 290, 19478-19488 (2015).
83. Jain, A., Balice-Gordon, R. Cellular, synaptic, and circuit effects ofantibodies in autoimmune CNS synaptopathies. Handb. Clin. Neurol. 133,77-93 (2016).
84. Bach, A., et al. A high-affinity, dimeric inhibitor of PSD-95 bivalently interactswith PDZ1-2 and protects against ischemic brain damage. Proc. Natl Acad. Sci.USA 109, 3317-3322 (2012).
85. Tiao, J. Y., et al. The sushi domains of secreted GABAB1 isoforms selectively impairGABAB heteroreceptor function. J. Biol. Chem. 283, 31005-31011 (2008).
86. Lowder, M. A., Appelbaum, J. S., Hobert, E. M., Schepartz, A. Visualizingprotein partnerships in living cells and organisms. Curr. Opin. Chem. Biol. 15,781-788 (2011).
87. Biermann, B., et al. The sushi domains of GABAB receptors function as axonaltargeting signals. J. Neurosci. 30, 1385-1394 (2010).
88. Guetg, N., et al. NMDA receptor-dependent GABAB receptor internalization viaCaMKII phosphorylation of serine 867 in GABAB1. Proc. Natl Acad. Sci. USA107, 13924-13929 (2010).
89. Kantamneni, S., et al. GISP: a novel brain-specific protein that promotessurface expression and function of GABAB receptors. J. Neurochem. 100,1003-1017 (2007).
90. Vertkin, I., et al. GABAB receptor deficiency causes failure of neuronalhomeostasis in hippocampal networks. Proc. Natl Acad. Sci. USA 112,E3291-E3299 (2015).
91. Gaillard, S., et al. GINIP, a Gi-interacting protein, functions as a keymodulator of peripheral GABAB receptor-mediated analgesia. Neuron 84,123-136 (2014).
92. Xie, K., et al. G 5 recruits R7 RGS proteins to GIRK channels to regulate thetiming of neuronal inhibitory signaling. Nat. Neurosci. 13, 661-663 (2010).
93. Tu, J. C., et al. Homer binds a novel proline-rich motif and links group 1metabotropic glutamate receptors with IP3 receptors. Neuron 21, 717-726(1998).
94. Choi, K. Y., Chung, S., Roche, K. W. Differential binding of calmodulin to groupI metabotropic glutamate receptors regulates receptor trafficking andsignaling. J. Neurosci. 31, 5921-5930 (2011).
95. Hu, J. H., et al. Preso1 dynamically regulates group I metabotropic glutamatereceptors. Nat. Neurosci. 15, 836-844 (2012).
96. Ko, S. J., et al. PKC phosphorylation regulates mGluR5 trafficking by enhancingbinding of Siah-1A. J. Neurosci. 32, 16391-16401 (2012).
97. Kitano, J., et al. Tamalin, a PDZ domain-containing protein, links a proteincomplex formation of group 1 metabotropic glutamate receptors and theguanine nucleotide exchange factor cytohesins. J. Neurosci. 22, 1280-1289(2002).
98. Kim, S. J., et al. Activation of the TRPC1 cation channel by metabotropicglutamate receptor mGluR1. Nature 426, 285-291 (2003).
99. Ferraguti, F., et al. Metabotropic glutamate receptor 8-expressing nerveterminals target subsets of GABAergic neurons in the hippocampus.J. Neurosci. 25, 10520-10536 (2005).